STOCK TITAN

HNI CORP (HNI) SEC Filings

HNI NYSE

Welcome to our dedicated page for HNI SEC filings (Ticker: HNI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

HNI Corporation filings document the formal disclosures of a NYSE-listed manufacturer of workplace furnishings and residential building products. The record includes Form 8-K reports for operating results, financial condition, material events, and exhibits tied to quarterly and annual earnings releases.

HNI filings also cover the completed Steelcase acquisition, including merger-related material-event reports, acquired-business financial statements, and unaudited pro forma combined financial information. Proxy materials disclose annual meeting matters such as director elections, auditor ratification, and executive compensation votes. Other filings address capital-structure matters, common stock registration information, operational improvement costs, material impairments, governance, and shareholder voting matters.

Rhea-AI Summary

HNI CORP (HNI) President & CEO Jeffrey D. Lorenger reported an options exercise and share sale. On August 28, 2026, he exercised 1,504 non‑qualifying employee stock options at an exercise price of $38.68 per share, receiving 1,504 shares of common stock, then sold those 1,504 shares at $50.00 per share. The filing notes the transactions were effected pursuant to a Rule 10b5-1 plan adopted on February 27, 2026. Following the exercise, he held 27,048 options directly and indirect common stock holdings of 313,061.462 shares by trust and 7,674.193 shares through a Profit Sharing Retirement Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

HNI CORP (HNI) is the issuer for a planned sale of its common stock by insider Jeffrey D. Lorenger under Rule 144. A brokerage account at Fidelity Brokerage Services LLC has filed to sell 1,504 shares of HNI common stock, related to a stock option exercise for cash dated August 28, 2026. The notice also lists several prior sales of HNI common shares by Lorenger during the past three months, with disclosed share amounts and dollar values.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

HNI CORP (HNI) reported insider transactions by President & CEO Jeffrey D. Lorenger involving option exercises and related stock sales over August 26–27, 2026. Lorenger exercised non‑qualifying employee stock options at an exercise price of $38.68 per share and received HNI common stock, then sold an equal number of shares in multiple open‑market transactions at weighted average prices of about $50 per share. The filing states these trades were effected under a Rule 10b5‑1 trading plan adopted on February 27, 2026. The report also notes indirect holdings of HNI common stock held by a trust and under a profit sharing retirement plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

HNI CORP (HNI) received a notice that company officer/director Jeffrey D. Lorenger intends to sell common stock under Rule 144. The notice covers up to 39,576 shares of HNI common stock, with an aggregate market value of $1,982,336.81, based on NYSE trading as of 08/27/2026. These shares were acquired from the issuer via stock option exercise for cash on the same date.

In addition, Lorenger reports prior sales of HNI common stock during the past three months: 45,850 shares for $2,180,204.18 on 08/03/2026, 700 shares for $35,005.01 on 08/24/2026, and 7,508 shares for $375,867.43 on 08/26/2026. Shares of HNI common stock outstanding were reported as 72,181,800.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

HNI CORP (HNI) has a Rule 144 notice filed for planned sales of its common stock by Jeffrey D. Lorenger. The notice states that 7,508 shares of HNI common stock are to be sold on 08/26/2026, in connection with a stock option exercise, through Fidelity Brokerage Services LLC for cash.

The filing also lists prior sales of HNI common stock for this account during the past three months: 45,850 shares on 08/03/2026 for proceeds of $2,180,204.05 and 700 shares on 08/24/2026 for $35,005.00. The notice is signed by Daniel Tucci as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Jeffrey D. Lorenger.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

HNI CORP (HNI) reported that President & CEO Jeffrey D. Lorenger exercised employee stock options for a total of 700 shares of common stock at an exercise price of $38.68 per share on August 24, 2026, and sold the same 700 shares at weighted-average prices of about $50.00 per share. The sales were effected pursuant to a Rule 10b5-1 plan adopted on February 27, 2026. Following these transactions, Lorenger reports indirect holdings of 313,061.462 shares held by a trust and 7,674.193 shares through a Profit Sharing Retirement Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

HNI CORP (HNI) received a notice that Jeffrey D. Lorenger intends to sell HNI common stock under Rule 144. The planned transaction involves 700 shares, expected to be sold on 08/24/2026 through Fidelity Brokerage Services LLC on the NYSE, in connection with a stock option exercise for cash.

During the prior three months, Lorenger reported an additional sale of 45,850 shares of HNI common stock on 08/03/2026 for total proceeds of $2,180,204.18. The Form 144 is signed by Jennifer Ruchti as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Lorenger.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

HNI Corporation (HNI) disclosed that its Board of Directors approved an additional expenditure of up to $200 million for repurchases of its outstanding Common Stock under the existing share repurchase program. As of August 17, 2026, HNI had $84.3 million of remaining authorization under this program.

Following the Board’s action, total share repurchase authorization under the program increased to $284.3 million. The program has no expiration date, does not require HNI to repurchase any shares, and its authorization may be terminated, increased, or decreased by the Board at any time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

HNI CORP (HNI) reported that director Timothy C. E. Brown acquired 263 shares of common stock on 2026-08-18 through a grant under the company’s 2017 Plan for Non-Employee Directors. The shares were received in lieu of quarterly board retainer fees of $12,500, bringing his direct holdings to 6,963 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

FMR LLC and Abigail P. Johnson report a significant ownership position in HNI CORP common stock. As of 06/30/2026, FMR LLC reports that it beneficially owns 10,634,659.54 shares of HNI common stock, representing 14.8% of the class. FMR LLC has sole voting power over 10,633,234 shares and sole dispositive power over 10,634,659.54 shares, with no shared voting or dispositive power.

Abigail P. Johnson is reported as having sole dispositive power over 10,634,659.54 shares and no voting power. One or more other persons have the right to receive dividends or sale proceeds on these shares, but no single such person has an interest exceeding five percent of the outstanding common stock. The position is held through subsidiaries identified in an attached exhibit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership

FAQ

How many HNI (HNI) SEC filings are available on StockTitan?

StockTitan tracks 130 SEC filings for HNI (HNI), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for HNI (HNI)?

The most recent SEC filing for HNI (HNI) was filed on September 1, 2026.